AstraZeneca announces BaxHTN phase III trial of baxdrostat demonstrated statistically significant and clinically meaningful reduction in systolic blood pressure in patients with hard-to-control ...

FIP sets out policy statement for responsible use of artificial intelligence in pharmacy practice: Our Bureau, Bengaluru Tuesday, September 2, 2025, 15:30 Hrs [IST] The Internatio ...

Our Bureau, Mumbai Tuesday, September 2, 2025, 14:15 Hrs [IST] ...

UTSA & UT Health San Antonio complete merger to become The University of Texas at San Antonio: San Antonio, Texas Tuesday, September 2, 2025, 15:00 Hrs [IST] UTSA and The Universi ...

Novartis Leqvio shows statistically significant and clinically meaningful early LDL-C goal achievement with less muscle pain: Basel Tuesday, September 2, 2025, 14:00 Hrs [IST] Nov ...

Care Hospitals, one of India’s leading healthcare providers, today announced the launch of its new state-of-the-art 24x7 ...

Clarivate to organise 16th annual Pharmavision India conference on Sept 3 at Taj Krishna in H’bad: Our Bureau, Bengaluru Tuesday, September 2, 2025, 12:00 Hrs [IST] Clarivate Pl ...

Zydus Lifesciences launches trivalent influenza vaccine, VaxiFlu in India: Our Bureau, Mumbai Tuesday, September 2, 2025, 13:30 Hrs [IST] Zydus Lifesciences Ltd., a global innovat ...

China NMPA approves Boehringer Ingelheim’s Hernexeos as first oral targeted therapy for previously treated patients with HER2-mutant advanced NSCLC: Ingelheim, Germany Tuesday, ...

Novo Nordisk’s Wegovy cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular disease: Bagsværd, ...

CapVest signs agreement with Bain Capital & Cinven to acquire the majority stake in STADA: Bad Vilbel, Germany Tuesday, September 2, 2025, 10:00 Hrs [IST] CapVest Partners LLP (Ca ...

ICMR issues draft standard protocols for evaluation of IVDs used for tuberculosis: Shardul Nautiyal, Mumbai Tuesday, September 2, 2025, 08:00 Hrs [IST] In a major collaborative ef ...